Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort.
Ferriero M, Mastroianni R, De Nunzio C, Cindolo L, Calabrò F, Tema G, Leonardo C, Flammia RS, Tuderti G, Anceschi U, Brassetti A, Giacinti S, Guaglianone S, Ghahhari J, Schips L, Tubaro A, Gallucci M, Simone G. Ferriero M, et al. Among authors: calabro f. World J Urol. 2020 Jul;38(7):1757-1764. doi: 10.1007/s00345-019-02974-6. Epub 2019 Oct 12. World J Urol. 2020. PMID: 31605196
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.
Sternberg CN, Dumez H, Van Poppel H, Skoneczna I, Sella A, Daugaard G, Gil T, Graham J, Carpentier P, Calabro F, Collette L, Lacombe D; EORTC Genitourinary Tract Cancer Group. Sternberg CN, et al. Among authors: calabro f. Ann Oncol. 2009 Jul;20(7):1264-9. doi: 10.1093/annonc/mdn784. Epub 2009 Mar 17. Ann Oncol. 2009. PMID: 19297314 Free article. Clinical Trial.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study.
Gacci M, Marchioni M, DE Francesco P, Natoli C, Calabrò F, Losanno T, Gianmartin C, Serni S, Doni L, DE Nunzio C, DE Tursi M, Valeriani M, Giacinti S, Álvarez-Maestro M, Scarcia M, Ludovico GM, Del Bene G, Simone G, Ferriero M, Tuderti G, Bove P, Laudisi A, Carrieri G, Cormio L, Verze P, LA Rocca R, Falsaperla M, Frantellizzi V, Greco F, DI Nicola M, Schips L, Cindolo L. Gacci M, et al. Among authors: calabro f. Minerva Urol Nephrol. 2021 Aug;73(4):489-497. doi: 10.23736/S2724-6051.20.03723-6. Epub 2020 Aug 4. Minerva Urol Nephrol. 2021. PMID: 32748613 Free article.
Neo-adjuvant chemotherapy in invasive bladder cancer.
Sternberg CN, Calabrò F. Sternberg CN, et al. Among authors: calabro f. World J Urol. 2001 Apr;19(2):94-8. doi: 10.1007/s003450000190. World J Urol. 2001. PMID: 11374324 Review.
276 results